Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
7.00
-0.25 (-3.45%)
At close: Feb 21, 2025, 4:00 PM
6.98
-0.02 (-0.27%)
After-hours: Feb 21, 2025, 6:44 PM EST
Ocular Therapeutix Employees
Ocular Therapeutix had 267 employees as of December 31, 2023. The number of employees decreased by 7 or -2.55% compared to the previous year.
Employees
267
Change (1Y)
-7
Growth (1Y)
-2.55%
Revenue / Employee
$230,120
Profits / Employee
-$652,951
Market Cap
1.10B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
OCUL News
- 19 days ago - Ocular Therapeutix™ Announces Upcoming Presentations at the Angiogenesis, Exudation, and Degeneration 2025 Virtual Meeting - GlobeNewsWire
- 5 weeks ago - Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Ocular Therapeutix™ Shares SOL-R Enrollment Progress and Next Steps for AXPAXLI™ in NPDR - GlobeNewsWire
- 7 weeks ago - Ocular Is Now Thoroughly Derisked - Seeking Alpha
- 2 months ago - Ocular Therapeutix™ to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Ocular Therapeutix™ Announces More Than 300 Subjects Randomized in SOL-1 - GlobeNewsWire
- 3 months ago - Ocular Therapeutix™ to Participate in December Investor and Scientific Conferences - GlobeNewsWire
- 3 months ago - Ocular Therapeutix, Inc. (OCUL) Q3 2024 Earnings Call Transcript - Seeking Alpha